arBtrage CAPITALIZING MARKETS checking… Sign in

enGene Therapeutics Inc.

ENGN Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.64
▼ -4.7% Today
as of Jun 7, 06:45 ET
Last 30 days -76.44% Apr 28 → Jun 05
$0.85 $3.00 $5.15 $7.29 $9.44 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.71
High
$1.74
Low
$1.61
Volume
$952,504
Avg Vol
$829,728
Mkt Cap
$115M
P/E (TTM)
1.08
Beta
52w High
$12.25
52w Low
$1.40
Div Yield
Shares Out
$67M

Overview

52-week range
$1.40
$12
2% of range
Avg surprise (last 1)
-2.0%
Avg reaction (last 1)
+0.9%
100% positive
Latest IV / EM
330%
EM ±45.7% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.51$1.94$4.40$6.85$9.30 Actual $9.30Actual $8.55Actual $0.46Actual $0.38Actual $0.32Actual $0.48Actual $0.51Actual $-0.51Est $-0.50Actual $0.44 AprJulJanAprJulJanAprApr/2025Jan
Revenue vs Net Income Revenue Net income
$-30M$-26M$-22M$-19M$-15M Apr 24Jul 24Jan 25Apr 25Jul 25Jan 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sat Jan 31, 2026Jan 2026 $0.44 financials
Thu Jun 12, 2025Apr/2025 $-0.51 $-0.50 -2.0% +0.9% earnings
Wed Apr 30, 2025Apr 2025 $0.51 financials
Fri Jan 31, 2025Jan 2025 $0.48 financials
Wed Jul 31, 2024Jul 2024 $0.32 financials
Tue Apr 30, 2024Apr 2024 $0.38 financials
Wed Jan 31, 2024Jan 2024 $0.46 financials
Mon Jul 31, 2023Jul 2023 $8.55 financials
Sun Apr 30, 2023Apr 2023 $9.30 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Jun 11, 2026Apr/2026OTHER -$0.48-$0.51 +5.9%

Financials

Income statement (quarterly)

MetricJan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024
Revenue
Cost of revenue
Gross profit
Operating income$-31M$-30M$-27M$-27M$-17M$-17M
Net income$-30M$-29M$-26M$-25M$-14M$-15M
EPS (diluted)$0.44$0.57$0.51$0.48$0.32$0.38

Balance sheet (quarterly)

MetricJan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024
Cash & equivalents$37M$50M$33M$58M$62M$173M$258M$265M
Inventory
Total current assets$289M$201M$211M$228M$222M$247M$263M$270M
Total assets$337M$221M$246M$267M$286M$311M$267M$274M
Long-term debt
Total liabilities$56M$54M$45M$39M$36M$39M$37M$31M
Total equity$282M$168M$201M$227M$250M$273M$230M$243M

Implied volatility — last 90 days

144%191%237%283%330% Jun 06 — IV 145% · EM ±25.7%Jun 07 — IV 330% · EM ±45.7%

Sector peers